Experts Share with Experts: The Roadmap to Virtual Engagement in Clinical Operations.
Without a doubt COVID-19 changed the engagement lifecycle overnight, forcing life science companies, like many others, to go virtual out of necessity. Although live interactions cannot be fully replicated, if you are running a clinical trial in 2021 and beyond, you’ll be among the minority if you aren’t planning to make virtual engagement a permanent part of how you interact. A panel of renowned experts will share best practices on engaging virtually, utilising technology to achieve valuable stakeholder engagement and creating better patient outcomes.
Learning Objectives:
- Navigating clinical trials by fostering active virtual discussions and global conversations
- Eliminating inefficient workflows that interfere with clinical trial activities
- Exploring the difference between virtual meetings and virtual work
- Designing the winning engagement strategies that enable faster decision-making
Speakers
Dr Cornelis Winnips
Global Program Clinical Head
Novartis
Dr Om Sharma
Senior Director, Global Oncology R&D
Daiichi- Sankyo
Blake A. Morrison, PhD
Global Medical and Scientific Affairs Expert
Multiple Myeloma Research Foundation
Lance Hill
Chief Executive Officer
Within3
